Novel Autologous Therapy for Long-Gap Peripheral Nerve Injury Using Human Sk-SCs

Autor: Maki Hirata, Tetsuro Tamaki, Masahiko Watanabe, Yoshiyasu Uchiyama, Nobuyuki Nakajima, Hiroyuki Hashimoto, Shuichi Soeda, Kosuke Saito
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Pathology
Macroglial Cells
Cell Transplantation
medicine.medical_treatment
Nerve guidance conduit
lcsh:Medicine
Nervous System
Mice
0302 clinical medicine
Nerve Fibers
Peripheral Nerve Injuries
Animal Cells
Medicine and Health Sciences
Morphogenesis
Blood and Lymphatic System Procedures
Axon
lcsh:Science
Myelin Sheath
Neurons
Multidisciplinary
Nerves
Stem Cells
Cell Differentiation
Stem-cell therapy
Anatomy
Animal Models
Muscle Differentiation
Sciatic Nerve
medicine.anatomical_structure
Peripheral nerve injury
Female
Endoneurium
Sciatic nerve
Stem cell
Cellular Types
Muscle Regeneration
Research Article
medicine.medical_specialty
Glial Cells
Surgical and Invasive Medical Procedures
Mouse Models
Biology
Research and Analysis Methods
03 medical and health sciences
Model Organisms
medicine
Animals
Humans
Regeneration
Cell Lineage
Muscle
Skeletal

Transplantation
lcsh:R
Biology and Life Sciences
Recovery of Function
Cell Biology
Axons
Nerve Regeneration
Disease Models
Animal

030104 developmental biology
Cellular Neuroscience
lcsh:Q
Schwann Cells
Perineurium
Organism Development
030217 neurology & neurosurgery
Stem Cell Transplantation
Developmental Biology
Neuroscience
Zdroj: PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0166639 (2016)
ISSN: 1932-6203
Popis: Losses in vital functions of the somatic motor and sensory nervous system are induced by severe long-gap peripheral nerve transection injury. In such cases, autologous nerve grafts are the gold standard treatment, despite the unavoidable sacrifice of other healthy functions, whereas the prognosis is not always favorable. Here, we use human skeletal muscle-derived stem cells (Sk-SCs) to reconstitute the function after long nerve-gap injury. Muscles samples were obtained from the amputated legs from 9 patients following unforeseen accidents. The Sk-SCs were isolated using conditioned collagenase solution, and sorted as CD34+/45- (Sk-34) and CD34-/45-/29+ (Sk-DN/29+) cells. Cells were separately cultured/expanded under optimal conditions for 2 weeks, then injected into the athymic nude mice sciatic nerve long-gap model (7-mm) bridging an acellular conduit. After 8-12 weeks, active cell engraftment was observed only in the Sk-34 cell transplanted group, showing preferential differentiation into Schwann cells and perineurial/endoneurial cells, as well as formation of the myelin sheath and perineurium/endoneurium surrounding regenerated axons, resulted in 87% of numerical recovery. Differentiation into vascular cell lineage (pericyte and endothelial cells) were also observed. A significant tetanic tension recovery (over 90%) of downstream muscles following electrical stimulation of the sciatic nerve (at upper portion of the gap) was also achieved. In contrast, Sk-DN/29+ cells were completely eliminated during the first 4 weeks, but relatively higher numerical (83% vs. 41% in axon) and functional (80% vs. 60% in tetanus) recovery than control were observed. Noteworthy, significant increase in the formation of vascular networks in the conduit during the early stage (first 2 weeks) of recovery was observed in both groups with the expression of key factors (mRNA and protein levels), suggesting the paracrine effects to angiogenesis. These results suggested that the human Sk-SCs may be a practical source for autologous stem cell therapy following severe peripheral nerve injury.
Databáze: OpenAIRE